Both in Pharmaceuticals
Oruka Therapeutics vs Axsome Therapeutics
Over the past year ORKA returned +269.7% and AXSM returned +1.5%; their daily moves had a correlation of 0.33.
ORKA +269.7% AXSM +1.5%Growth of $1, one year, split-adjusted
| Metric | ORKA | AXSM |
|---|---|---|
| Price | $101.41 | $137.00 |
| Market cap | $6.71B | $7.18B |
| Today | +1.87% | −1.87% |
| 1 month | +26.5% | −21.4% |
| 6 months | +45.3% | −38.5% |
| Year to date | +234.6% | −25.0% |
| 1 year | +287.2% | +0.9% |
| Revenue growth (YoY) | — | +51.9% |
| Gross margin | — | 93.1% |
| Net margin | — | −5.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 8.3× |
| Net cash | $873.6M | $116.6M |
| Dividend yield | — | — |
| Volatility (60d) | 51.8% | 38.0% |
| Short % of float | 11.5% | 7.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).